Between January 2000 and November 2012, patients aged < 18 years at the time of HTx, who had at least one session of CFR measurement at the time of annual endomyocardial biopsy (EBM) at our institute, were enrolled. Patients died during the first 30 days after HTx were excluded. Stenotic MVP was identified with light microscopy (¡Á200) evaluations, defined as stenotic endothelial and/or medial changes of microvessels (diameter 10 to 20¦Ìm). Patients were divided in two groups; stenotic and non stenotic MVP. CFR were compared between those groups.
25 patients (male: 12, average month at HTx, 108¡À79 months) underwent 127 EBM (average duration after HTx, 52 ¡À35 months). Of those CFR was measured concomitantly in 71 studies. Average CFR was 2.1 ¡À 1.4. Of 71 specimens, 36 were defined as stenotic. CFR was significantly lower in stenotic group compared with non stenotic group (1.5 ¡À 0.3 versus 2.7 ¡À0.8; P=0.041).
Coronary Flow Reserve measured with DFW might be effective in clarifying the myocardial microvasculopathy in patients after pediatric HTx.